HMGB1 and neoplasm: Tumor cells can induce ICD by expos to calreticulin (CRT) and releasing high mobility group protein B1 (HMGB1), this promotes the recruitment of antigen presenting cells (APCs) and tumor infiltration of T cells, which contribute to the activation of antitumor immune responses (Sun et al., 2020; Jin and Wang, 2021).